Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination

COVID-19 continues to impact healthcare workers (HCWs), making it crucial to investigate vaccine response rates. This study examined HCWs’ humoral and cellular immunological responses to COVID-19 booster dosages. We enrolled thirty-four vaccinated HCWs. Twelve received a booster. Post-immunization,...

Full description

Bibliographic Details
Published in:	Current Issues in Molecular Biology
Main Authors:	Lina Souan, Hikmat Abdel-Razeq, Maher A. Sughayer
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Subjects:	COVID-19 SARS-CoV-2 immune response vaccines long immunity infection
Online Access:	https://www.mdpi.com/1467-3045/46/10/660

Similar Items

Persistence of SARS-CoV-2-antibodies against N, S and RBD after natural infection
by: Mitra Jafari, et al.
Published: (2023-11-01)

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice
by: Feng-Xia Gao, et al.
Published: (2022-12-01)

Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers
by: Agata Błaszczuk, et al.
Published: (2022-07-01)

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
by: Lina Souan, et al.
Published: (2022-04-01)

Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
by: Maher A. Sughayer, et al.
Published: (2021-06-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

Antibody Kinetics of Immunological Memory in SARS-CoV-2-Vaccinated Healthcare Workers—The ORCHESTRA Project
by: Seyedalireza Seyedi, et al.
Published: (2025-06-01)

A Systematic Evaluation of the SARS-CoV-2 Vaccine-Induced Anti-S-RBD-Ig Response in a Population of Health Care Workers
by: Viktoria Hentschel, et al.
Published: (2023-09-01)

Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination
by: Francisco J. Cimas, et al.
Published: (2023-01-01)

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
by: Thomas Theo Brehm, et al.
Published: (2021-04-01)

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study
by: Lina Souan, et al.
Published: (2023-10-01)

The Effect of the Immunization Schedule and Antibody Levels (Anti-S) on the Risk of SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers in Northern Italy
by: Emanuele Sansone, et al.
Published: (2023-03-01)

Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters
by: Xiaochun Susan Zhang, et al.
Published: (2024-10-01)

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
by: Aleksandr V. Kudriavtsev, et al.
Published: (2022-07-01)

Severity of SARS-CoV-2 reinfection in vaccinated healthcare workers
by: Fatemeh Golshahi, et al.
Published: (2023-04-01)

An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations
by: Lina Souan, et al.
Published: (2022-07-01)

Anti-RBD immunoglobulin levels and their predictive value for SARS-CoV-2 neutralization
by: Sabine Lichtenegger, et al.
Published: (2025-05-01)

Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers
by: Salvagno Gian Luca, et al.
Published: (2022-01-01)

RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
by: Hernan H. M. da Costa, et al.
Published: (2023-02-01)

Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
by: Huijie Yang, et al.
Published: (2024-12-01)

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
by: Syamala Rani Thimmiraju, et al.
Published: (2023-10-01)

Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA
by: Xuanxuan Zhang, et al.
Published: (2025-05-01)

Dynamics of Antibody and T Cell Immunity against SARS-CoV-2 Variants of Concern and the Impact of Booster Vaccinations in Previously Infected and Infection-Naïve Individuals
by: Michel R. Faas, et al.
Published: (2022-12-01)

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
by: Astrid K. Hvidt, et al.
Published: (2022-10-01)

Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics
by: Ana Paula Moreira Franco-Luiz, et al.
Published: (2023-07-01)

Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers
by: Laura V. Renna, et al.
Published: (2023-02-01)

From immune evasion to broad in silico binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody
by: Shuyuan Cao, et al.
Published: (2025-08-01)

The impact of N-glycans on the immune response of plant-produced SARS-CoV-2 RBD-Fc proteins
by: Theerakarn Srisangsung, et al.
Published: (2024-09-01)

Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development
by: Xinghang Li, et al.
Published: (2024-01-01)

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers
by: Federico Pratesi, et al.
Published: (2021-06-01)

Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers
by: Sara Caldrer, et al.
Published: (2024-02-01)

Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
by: Leah J. Ricketson, et al.
Published: (2024-07-01)

Ginseng Polysaccharide Enhances the Humoral and Cellular Immune Responses to SARS-CoV-2 RBD Protein Subunit Vaccines
by: Jing Zhang, et al.
Published: (2023-12-01)

Seroprevalence of SARS-COV-2 antibodies among school-age children in the Swabi district of Pakistan
by: Muhammad Arif, et al.
Published: (2024-03-01)

SARS-COV-2, can you be over it?
by: Alessandro Fiocchi, et al.
Published: (2021-02-01)

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
by: Lina Souan, et al.
Published: (2023-06-01)

Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19
by: Andres Agurto-Arteaga, et al.
Published: (2022-05-01)

SARS-CoV-2 mRNA vaccine candidate encoding RBD chimera of Delta and Omicron variants: immunogenic potential and validation
by: Shahla Shahsavandi, et al.
Published: (2025-10-01)

Seroprevalence of endemic and emergent coronaviruses among SARS-COV-2 patients and healthcare workers in Abidjan, Côte d’Ivoire
by: Arthur Menezes, et al.
Published: (2026-03-01)